v3.26.1
Income Taxes - Schedule of Deferred Tax Assets (Details) - USD ($)
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Deferred tax assets:      
Net operating loss $ 1,713,110 $ 1,416,684  
Stock options 832,484 903,449  
Operating right-of-use liability 444,981 519,058  
Inventory 255,855 187,534  
Capitalized research and development costs 167,957 241,761  
Research and development tax credits 27,632  
Deferred expenses 18,995  
Total deferred tax assets 3,461,014 3,268,486  
Valuation allowance (2,666,961) (2,319,591) $ (2,537,690)
Deferred tax assets, net of valuation allowance 794,053 948,895  
Deferred tax liabilities:      
Depreciation 419,146 492,376  
Operating right-of-use asset 374,907 456,519  
Total deferred tax liabilities 794,053 948,895  
Deferred tax asset (liability), net